Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2017-06-13
Original market date: See footnote 1
Product name:
SENNA-DOCUSATE TABLETS
DIN:
02291290 Electronic product monograph is not available
Company:
INTERNATIONAL PHARMACEUTICAL GENERICS LTD
4-77 Auriga Drive
Ottawa
Ontario
Canada
K2E 7Z7
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A06AB56 SENNA GLYCOSIDES, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0215780001
Active ingredient(s) | Strength |
---|---|
DOCUSATE SODIUM | 50 MG |
SENNOSIDES (CALCIUM SENNOSIDES A & B) | 8.6 MG |